National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:48:48
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0270-0149-60 | ML - Milliliter | 0270-0149 | 7e901fa0-0046-48d2-af20-0a7abca18e14 | 1 | 2013-02-13 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0270-0149 | 0270-0149-60 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010040-001 | RENOGRAFIN-76 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | ||
| N010040-006 | RENOGRAFIN-60 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-012 | RENO-DIP | DIATRIZOATE MEGLUMINE | 30% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-016 | RENO-60 | DIATRIZOATE MEGLUMINE | 60% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-017 | DIATRIZOATE MEGLUMINE | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-018 | CYSTOGRAFIN | DIATRIZOATE MEGLUMINE | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | ||
| N010040-019 | RENOVIST II | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-020 | RENOVIST | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-021 | RENO-30 | DIATRIZOATE MEGLUMINE | 30% | SOLUTION / URETERAL | Approved before 1982 | ||
| N010040-022 | CYSTOGRAFIN DILUTE | DIATRIZOATE MEGLUMINE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | 011fe1cb6892… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cystografin | DIATRIZOATE MEGLUMINE | BRACCO DIAGNOSTICS INC | 7496d736-9f7d-4136-ad5d-b24c7803c21b | 2025-11-23 | Warnings, Adverse reactions | 0270-0149-60 00270014960 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.